Please note: AABB reserves the right to make updates to this program.
Live Program: Thursday, September 7, 2017 - On-Demand Available
Master Program Number: 17EL-155 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Physicians, Nurses, Managers/Supervisors, Medical Directors, Students/Fellows, Residents
Teaching Level: Intermediate
Director/Moderator: Kathleen Puca, MD, Blood Center of Wisconsin, Milwaukee, WI
Speakers: Katharine Downes, MD, Medical Director, University Hospitals Cleveland Medical Center, Cleveland, OH; Karen King, MD, Associate Medical Director, Transfusion Medicine, Professor of Pathology, Johns Hopkins Medical Institute, Baltimore, MD
After participating in this educational activity, participants should be able to:
- Explain how a revitalized scope, charge, and composition of one’s Transfusion Committee can bring value to the institution and provide opportunities for continuous improvement.
- Describe the capabilities and opportunities that EHRs provide to access and analyze transfusion and clinical data for improving patient care.
- Discuss the application of Hemovigilance activities, definitions, and practices in the Transfusion Committee to promote a broader use of Hemovigilance in your organization.
This era of cost reduction imperatives and a shift to value-based medicine, Transfusion Committees have an opportunity if not an imperative to “re-invent” themselves and refocus on defining and documenting value that transfusion medicine physicians, specialists, and activities bring to a healthcare institution. In addition, electronic health records (EHRs) provide potential capabilities for Transfusion Committee’s to access and to analyze transfusion and clinical data in ways not previously possible.
Transfusion Committees may consider getting nontraditional stakeholders involved. This program will offer suggestions for Transfusion Committees to consider for adapting to the needs of the current and future care environment. Topics covered include using service line-based utilization and cost data to engage clinical service lines directly and add members to Transfusion Committees; using the EHR to monitor and analyze transfusion practices and the relationship between the TC and EHR team; and applying concepts and definitions from Hemovigilance into Transfusion Committee activities as a stepping stone to standardizing on Hemovigilance-compliant classification of efforts, incidents, and reactions across an organization.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||